Ariad Pharmaceuticals, Inc. Announces Appointment Of Hugh Cole, Senior Pharmaceutical-Industry Executive, As Chief Business Officer
Published: Apr 02, 2014
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the appointment of Hugh M. Cole to the position of senior vice president and chief business officer. Mr. Cole will be responsible for global business and corporate development, licensing and strategic planning. He will report to ARIAD’s chairman and chief executive officer, Harvey J. Berger, M.D.
Help employers find you! Check out all the jobs and post your resume.